Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serkan Demir

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Brain and Behavior|July 21, 2025
Exploring Social Cognition Sub-Domains and Predictors in Multiple Sclerosis: A Cross-Sectional StudyOzlem Totuk, Merve Turkkol, Ebru Hatun Uludaşdemir, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2024
Prevalence and incidence of multiple sclerosis in Turkey: A nationwide epidemiologic studyBilgin Öztürk, Esra Taşkıran, Serkan Demir, et al.
Multiple Sclerosis and Related Disorders|April 30, 2026
Beyond serology: clinical and prognostic determinants in patients with dual AQP4-IgG and MOG-IgG seropositivityIpek Gungor Dogan, Sedat Sen, Damla Cetinkaya Tezer, et al.
Noro Psikiyatri Arsivi|September 26, 2022
The Socioeconomic and Psychological Impact of the COVID-19 Pandemic on People with Multiple Sclerosis in TurkeyTuncay Gündüz, Cihat Uzunköprü, Serkan Demir, et al.
Noro Psikiyatri Arsivi|September 15, 2025
Live Cell-Based Flow Cytometry Assay Versus Commercial Cell-Based Indirect Immunofluorescence Assay of Aquaporin-4 Antibody in Neuromyelitis Optica: A Comparative Studyİpek Güngör Doğan, Mesut Yiğit, Damla Çetinkaya Tezer, et al.
The Neurologist|June 4, 2025
Current Approach to Perioperative Evaluation of Neurological DiseasesÖzdem Ertürk Çetin, Özlem Totuk, İpek Güngör Doğan, et al.
Multiple Sclerosis and Related Disorders|February 11, 2024
Clinical and demographic characteristics of late-onset multiple sclerosis: LOMS-TR studyAli Özhan Sıvacı, Meral Seferoğlu, Bilge Piri Çınar, et al.
Acta Neurologica Belgica|June 24, 2025
Understanding stigma in multiple sclerosis: workplace discrimination, social challenges and psychological impactsNazlı Gamze Bülbül, Abdulkadir Tunç, Sena Destan Bünül, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 19, 2025
Treatment Adherence in a Large Cohort of Turkish Multiple Sclerosis PopulationMeral Seferoğlu, Bilge Piri Çınar, Ülgen Yalaz Tekan, et al.
International Journal of Clinical Practice|March 20, 2021
The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from TurkeyCihat Uzunköprü, Melih Tütüncü, Tuncay Gündüz, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Brain and Behavior|July 21, 2025
Exploring Social Cognition Sub-Domains and Predictors in Multiple Sclerosis: A Cross-Sectional StudyOzlem Totuk, Merve Turkkol, Ebru Hatun Uludaşdemir, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2024
Prevalence and incidence of multiple sclerosis in Turkey: A nationwide epidemiologic studyBilgin Öztürk, Esra Taşkıran, Serkan Demir, et al.
Multiple Sclerosis and Related Disorders|April 30, 2026
Beyond serology: clinical and prognostic determinants in patients with dual AQP4-IgG and MOG-IgG seropositivityIpek Gungor Dogan, Sedat Sen, Damla Cetinkaya Tezer, et al.
Noro Psikiyatri Arsivi|September 26, 2022
The Socioeconomic and Psychological Impact of the COVID-19 Pandemic on People with Multiple Sclerosis in TurkeyTuncay Gündüz, Cihat Uzunköprü, Serkan Demir, et al.
Noro Psikiyatri Arsivi|September 15, 2025
Live Cell-Based Flow Cytometry Assay Versus Commercial Cell-Based Indirect Immunofluorescence Assay of Aquaporin-4 Antibody in Neuromyelitis Optica: A Comparative Studyİpek Güngör Doğan, Mesut Yiğit, Damla Çetinkaya Tezer, et al.
The Neurologist|June 4, 2025
Current Approach to Perioperative Evaluation of Neurological DiseasesÖzdem Ertürk Çetin, Özlem Totuk, İpek Güngör Doğan, et al.
Multiple Sclerosis and Related Disorders|February 11, 2024
Clinical and demographic characteristics of late-onset multiple sclerosis: LOMS-TR studyAli Özhan Sıvacı, Meral Seferoğlu, Bilge Piri Çınar, et al.
Acta Neurologica Belgica|June 24, 2025
Understanding stigma in multiple sclerosis: workplace discrimination, social challenges and psychological impactsNazlı Gamze Bülbül, Abdulkadir Tunç, Sena Destan Bünül, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 19, 2025
Treatment Adherence in a Large Cohort of Turkish Multiple Sclerosis PopulationMeral Seferoğlu, Bilge Piri Çınar, Ülgen Yalaz Tekan, et al.
International Journal of Clinical Practice|March 20, 2021
The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from TurkeyCihat Uzunköprü, Melih Tütüncü, Tuncay Gündüz, et al.
Pageof 8